Measuring nerve changes in people with Type 1 diabetes
Part of Brain & nervous system, Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at how a diabetes “artificial pancreas” or insulin delivery method affects nerve problems (diabetic neuropathy) over time. It may help researchers better understand which diabetes treatments are linked to fewer or different nerve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Type 1 diabetes and are between 18 and 70 years old
- You can read and understand English well enough for study instructions
- You are starting one of these for clinical reasons: an artificial pancreas, an insulin pump, or multiple daily insulin shots
- You must not have eye or cornea problems that could affect the cornea (the clear front part of the eye)
- You must not have certain recent eye injuries or infections/inflammation, or specific non-diabetes causes of nerve damage
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a hybrid closed-loop system that automatically adjusts insulin delivery. It may help you manage your blood sugar more easily if you currently give yourself daily insulin shots.
This study tests a new approach to help people with type 1 diabetes who have high blood sugar (A1c above 8.5%) and are not on an insulin pump. It looks at whether using diabetes technology can improve your glucose control.
This trial tests whether a closed-loop insulin pump combined with education can help people with type 1 diabetes better recognize and avoid dangerously low blood sugar. It may be a good fit if you've had diabetes for a long time and have trouble sensing when your blood sugar drops.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests an upgraded automated insulin pump system that uses artificial intelligence to better predict and prevent blood sugar swings. If you have Type 1 Diabetes and already use an automated insulin pump, this trial may help you achieve better blood sugar control.
Hear when a new Diabetes Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.